Form 4: Guardant Health Executive Reports Stock Transactions
SEC Form 4 Filing
John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On July 1, 2024, John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- Saia acquired 974 shares of common stock through the vesting of restricted stock units (RSUs).
- Simultaneously, 348 shares were withheld by the company to cover tax obligations related to the RSU vesting at a price of $28.26 per share.
- Following these transactions, Saia directly owns 29,043 shares of Guardant Health common stock.
- Saia also holds 8,766 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by an executive, with no inherently positive or negative implications.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of restricted stock unit award grant. |
| October 1, 2023 | 25% of the shares subject to the restricted stock unit award vested. |
| July 1, 2024 | Date of the reported transactions: RSU vesting and tax withholding. |
| July 2, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.